CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma.Yi Lin, Sundar Jagannath, Alexander M. Lesokhin et al.|Journal of Clinical Oncology|2023Cited by 117
S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMANikhil C. Munshi, Sundar Jagannath, Tom Martin et al.|HemaSphere|2023Cited by 20
P-275 CARTITUDE-1 final results: phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myelomaSundar Jagannath, Yi Lin, Thomas Martin et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 4
MM-309 CARTITUDE-1 Final Results: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Heavily Pretreated Patients With Relapsed/Refractory Multiple MyelomaYi Lin, Sundar Jagannath, Thomas Martin et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 1